These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21862156)

  • 41. Natriuretic peptides: the feline experience.
    Connolly DJ
    Vet Clin North Am Small Anim Pract; 2010 Jul; 40(4):559-70. PubMed ID: 20610011
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischaemic origin.
    Stanton E; Hansen M; Wijeysundera HC; Kupchak P; Hall C; Rouleau JL;
    Eur J Heart Fail; 2005 Jun; 7(4):557-65. PubMed ID: 15921795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP.
    Hogenhuis J; Voors AA; Jaarsma T; Hillege HL; Boomsma F; van Veldhuisen DJ
    Eur J Heart Fail; 2005 Jan; 7(1):81-6. PubMed ID: 15642536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac biomarkers in the critically ill.
    Ventetuolo CE; Levy MM
    Crit Care Clin; 2011 Apr; 27(2):327-43. PubMed ID: 21440204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Natriuretic peptides as cardiac markers in clinical practice].
    Veien KT; Jensen JK; Hildebrandt P; Gøtze JP; Nielsen OW; Køber L
    Ugeskr Laeger; 2010 Jul; 172(30):2111-6. PubMed ID: 20654278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization.
    Sir JJ; Chung WY; Hwang SJ; Kang HJ; Cho YS; Koo BK; Chae IH; Choi DJ; Kim HS; Sohn DW; Kim CH; Oh BH; Park YB; Choi YS
    Int J Cardiol; 2008 Jun; 126(3):322-32. PubMed ID: 17544525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
    Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
    J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atrial fibrillation after thoracic surgery for lung cancer: use of a single cut-off value of N-terminal pro-B type natriuretic peptide to identify patients at risk.
    Salvatici M; Cardinale D; Spaggiari L; Veglia F; Tedesco CC; Solli P; Cipolla CM; Zorzino L; Passerini R; Riggio D; Cassatella MC; Sandri MT
    Biomarkers; 2010 May; 15(3):259-65. PubMed ID: 20030573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
    Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of the diagnostic accuracy of circulating natriuretic peptide concentrations to distinguish between cats with cardiac and non-cardiac causes of respiratory distress.
    Connolly DJ; Soares Magalhaes RJ; Fuentes VL; Boswood A; Cole G; Boag A; Syme HM
    J Vet Cardiol; 2009 May; 11 Suppl 1():S41-50. PubMed ID: 19394286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma N-terminal prohormone brain natriuretic peptide as a marker for postoperative cardiac events in high-risk patients undergoing noncardiac surgery.
    Schutt RC; Cevik C; Phy MP
    Am J Cardiol; 2009 Jul; 104(1):137-40. PubMed ID: 19576335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The predictive ability of pre-operative B-type natriuretic peptide in vascular patients for major adverse cardiac events: an individual patient data meta-analysis.
    Rodseth RN; Lurati Buse GA; Bolliger D; Burkhart CS; Cuthbertson BH; Gibson SC; Mahla E; Leibowitz DW; Biccard BM
    J Am Coll Cardiol; 2011 Jul; 58(5):522-9. PubMed ID: 21777751
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Safe diagnosis in acute phase with T-proBNP. Heart failure and acute coronary syndrome can be identified very early].
    Javadzadeh J; Collén AC; Manhem K; Swedberg K
    Lakartidningen; 2008 Feb 27-Mar 4; 105(9):616-9. PubMed ID: 18376704
    [No Abstract]   [Full Text] [Related]  

  • 55. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.
    Hoffmann U; Brueckmann M; Bertsch T; Wiessner M; Liebetrau C; Lang S; Haase KK; Borggrefe M; Huhle G
    Clin Lab; 2005; 51(7-8):373-9. PubMed ID: 16122147
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glomerular filtration rate and N-terminal pro-brain natriuretic peptide as predictors of cardiovascular mortality in vascular patients.
    Shadman R; Allison MA; Criqui MH
    J Am Coll Cardiol; 2007 Jun; 49(22):2172-81. PubMed ID: 17543637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natriuretic peptides as markers of cardiovascular risk: the story continues.
    Ventura HO; Silver MA
    Mayo Clin Proc; 2011 Dec; 86(12):1143-5. PubMed ID: 22134932
    [No Abstract]   [Full Text] [Related]  

  • 58. Natriuretic peptides as markers of cardiovascular disease. Their use in diagnosis, prognosis and therapy.
    de Bold AJ
    Rev Fac Cien Med Univ Nac Cordoba; 2003; 60(1):43-8. PubMed ID: 16724441
    [No Abstract]   [Full Text] [Related]  

  • 59. [Value of biological markers in cardiovascular disease].
    Couderc R; Lefevre G; Fiessinger JN
    Bull Acad Natl Med; 2012 Jan; 196(1):217-22. PubMed ID: 23259345
    [No Abstract]   [Full Text] [Related]  

  • 60. N-terminal prohormone brain natriuretic peptide: a biomarker for detecting cardiovascular risks in patients with rheumatoid arthritis or osteoarthritis?
    Häupl T; Burmester GR; Giannitsis E; Rohrlach T; Spanuth E; Parsch H; Brune K
    Ann Rheum Dis; 2007 Jun; 66(6):838-9. PubMed ID: 17513573
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.